Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2005
07/14/2005WO2005063748A1 β-CARBOLINE DERIVED GUANIDINE ALKALOID, TIRUCHENDURAMINE
07/14/2005WO2005063747A1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
07/14/2005WO2005063746A1 PYRROLO[2,3-b]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
07/14/2005WO2005063745A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
07/14/2005WO2005063744A2 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
07/14/2005WO2005063739A1 Novel quinoline derivatives
07/14/2005WO2005063704A1 Azetidine ring compounds and drugs comprising the same
07/14/2005WO2005062991A2 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
07/14/2005WO2005062795A2 Compounds and methods for development of ret modulators
07/14/2005WO2005056550A3 Heterocyclic anti-migraine agents
07/14/2005WO2005046612A3 Hydroxy piperidine derivatives to treat gaucher disease
07/14/2005WO2005040073A3 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids
07/14/2005WO2004113277A8 Methods and compositions for treating amyloid-related diseases
07/14/2005US20050154208 Efficient electron transport and hole blocking; organic electroluminescent device
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
07/14/2005US20050154014 Anticarcinogenic agents; antitumor agents treating cancer of breast, head, neck, gastrointestinal system or stomach, ovaries, bronchi, lungs or pancreas; leukemia
07/14/2005US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/14/2005US20050154008 Aryl fused substituted 4-oxy-pyridines
07/14/2005US20050154007 Substituted imidazo[1,2-a]pyridines such as 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-6-methoxyimidazo[1,2-a]pyridine, used as antisectory agents for prophylaxis of gastrointestinal disorders
07/14/2005US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition
07/14/2005US20050154001 cCs-rac-4-phenyl-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one; treating diseases related to activation of NMDA receptors via Glyt-1 inhibition
07/14/2005US20050154000 Diaza-spiropiperidine derivatives
07/14/2005US20050153998 Tetrahydroisoquinoline or isochroman compounds
07/14/2005US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one
07/14/2005US20050153980 Substituted indoles
07/14/2005US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof
07/14/2005US20050153978 Medicaments
07/14/2005US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
07/14/2005US20050153964 Novel compounds
07/14/2005US20050153960 Substituted arylamine derivatives and methods of use
07/14/2005US20050153959 Heterocyclic anti-migraine agents
07/14/2005US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof
07/14/2005US20050151467 Electrochromic salts, solutions, and devices
07/14/2005CA2552207A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
07/14/2005CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005CA2550689A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
07/14/2005CA2550686A1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
07/14/2005CA2550361A1 Compounds and methods for development of ret modulators
07/14/2005CA2549898A1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
07/14/2005CA2549606A1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
07/14/2005CA2546147A1 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
07/13/2005EP1553099A1 A riboflavin derivative and its manufacture and uses
07/13/2005EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
07/13/2005EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore
07/13/2005EP1552842A1 Bicyclic pyrimidine derivatives
07/13/2005EP1552836A1 Anti-neurodegenerative agents
07/13/2005EP1551902A2 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making
07/13/2005EP1551849A1 Tricyclic tetrahydroquinoline antibacterial agents
07/13/2005EP1551844A2 Antitumoral analogs of lamellarins
07/13/2005EP1551840A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
07/13/2005EP1551836A1 Azabicyclic amine derivatives as nk-1 receptor antagonists
07/13/2005EP1551835A1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
07/13/2005EP1551834A1 Substituted quinazolinone compounds
07/13/2005EP1551831A1 Method for preparing risperidone
07/13/2005EP1551829A2 Novel compounds with antibacterial activity
07/13/2005EP1551828A1 Pyrazole derivatives
07/13/2005EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
07/13/2005EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders
07/13/2005EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
07/13/2005EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/13/2005EP1551461A2 Azo compounds for type i phototherapy
07/13/2005EP1551400A2 Preparation of triazospiro compounds
07/13/2005EP1551398A1 Pyrazolopyridines and methods of making and using the same
07/13/2005EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity
07/13/2005EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
07/13/2005EP0977755B1 Heterocyclic compounds and their preparation and use
07/13/2005CN1639165A Purine derivatives as kinase inhibitors
07/13/2005CN1639163A Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6, 7, 8, 9-tetrahydro-4h-pyrido-(1, 2-a) pyrimidin-4-one
07/13/2005CN1639162A Pyrido(2, 1-a)isoquinoline derivatives as DPP-IV inhibitors
07/13/2005CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors
07/13/2005CN1639160A Process for preparing crystalline form I of cabergoline
07/13/2005CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors
07/13/2005CN1639147A Synthesis of 4, 5-dihydro-pyrazolo [3, 4-c] pyrid-2-ones
07/13/2005CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
07/13/2005CN1639125A New inhibitors of histone deacetylase
07/13/2005CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
07/13/2005CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs
07/13/2005CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
07/13/2005CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
07/13/2005CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
07/13/2005CN1636995A Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material using the derivatives
07/13/2005CN1636992A Process for producing quinazoline ditosylate salt compounds
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1210277C Heteroaryl diazabicycloalkanes, their prepn. and use
07/13/2005CN1210275C Respiratory syncytial virus replication inhibitors
07/13/2005CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use
07/13/2005CN1210265C Phthalazine derivatives and remedies for erectile dysfunction
07/12/2005US6916928 Functionalized perylene tetracarboxylic acid diimides
07/12/2005US6916925 Dye labeled imidazoquinoline compounds
07/12/2005US6916827 Central nervous system disorders
07/12/2005US6916826 Substituted imidazo[1,2-a]pyridine derivatives
07/12/2005US6916825 Alkylated imidazopyridine derivatives
07/12/2005US6916819 Benzimidazole and pyridylimidazole derivatives
07/12/2005US6916818 Nitrogen compounds such as 1-(1-Naphthalenesulfonyl)-3-(octa-hydro-4-quinolizinyl)-1H-5-azaindole, used as serotonin receptor antagonists for prophylaxis of psychological disorders
07/12/2005US6916810 αν integrin receptor antagonists
07/12/2005US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme